Eta Diagnostics, Inc. (ETAD) is a New Mexico C-Corp that is devoted to the development and commercialization of the high throughput “massively parallel” flow cytometry technology invented by Prof. Steven W. Graves and Prof. Andrew P. Shreve at the University of New Mexico’s Center for Biomedical Engineering (UNM/CBME). The Company’s disruptive technology holds great promise in a variety of life science applications, including the detection and analysis of Circulating Tumor Cells (CTCs). ETAD is currently being incubated within Sandia Electro-Optics Corporation (SE-OC), which has an exclusive intellectual property licensing agreement with UNM’s Science and Technology Corporation (STC.UNM) that covers ETAD’s four US patents (2 patents issued, 2 patents pending). For more information, please send an email to Info@EtaDiagnostics.com or call Sandia Electro-Optics Corporation at 505-816-0211.
Click to see the ETA Diagnostics CYTO 2014 presentation